Evidence map›Paper›PMID 42393234›Full record

ArticleEMBO reports2026

Lipid droplets promote aberrant liquid-liquid phase separation of alpha-synuclein impairing energy homeostasis.

Jose Cevallos, Elena Eubanks, Sunghoo Jung, Yiming Huang, Elyse Guadagno, Nora Jaber, Yuzhou Xia, Jinying Wang, Huan Wang, Neeharika Rao Suvvari and 18 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Jose Cevallos *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.ORCID 0009-0004-2714-9937
Elena Eubanks *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Sunghoo Jung *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Yiming Huang *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Elyse Guadagno *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Nora Jaber *Department of Cell Biology and Neuroscience & Institute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, USA.
Yuzhou Xia *Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USA.
Jinying Wang *Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USA.ORCID 0009-0006-3737-4585
Huan Wang *Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USA.
Neeharika Rao SuvvariDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Aryan DoshiDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Nitya RavinutalaDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.ORCID 0009-0009-5752-372X
Alejandro MoseraDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Timothy HsuDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Jiya ModyDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Benjamin SacksDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Anvi NarayanDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Breanna SmithDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.ORCID 0009-0001-0522-0470
Maia WangDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Meghana GottapuDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
Heba AlnakhalaAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Nagendran RamalingamAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-9459-3593
Arati TripathiAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Tim BartelsUK Dementia Research Institute, University College London, London, UK.ORCID 0000-0002-4071-5612
Ulf DettmerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-6676-0107
Zheng ShiDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USA.ORCID 0000-0002-5214-1871
Wei DaiDepartment of Cell Biology and Neuroscience & Institute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, USA.
Eleanna KaraDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA. ek851@rwjms.rutgers.edu.ORCID 0000-0001-5428-6743

Funding

How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in AnimalsRF1NS133979 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI DETTMER, ULF, RAMALINGAM, NAGENDRAN · 2023 to 2023
$2.2M
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic ActivityRF1NS122880 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI DETTMER, ULF, RAMALINGAM, NAGENDRAN · 2022 to 2022
$2.1M
Understanding the viscoelasticity, surface tension, and membrane interactions of biomolecular condensates in live cellsR35GM147027 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI Zheng Shi · 2022 to 2026
$1.6M
Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic ActivityR01NS122880 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Ulf Dettmer, Nagendran Ramalingam · 2025 to 2026
$1.4M
Summer Undergraduate Research Program (SURP) in Molecular and Developmental NeurobiologyR25NS105143 · NINDS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI M. CHIARA MANZINI, Mladen Roko Rasin · 2018 to 2026
$904k
How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in AnimalsR01NS133979 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Ulf Dettmer, Nagendran Ramalingam · 2026 to 2026
$724k
Distinguishing α-Synuclein S129 Phosphorylation in Health and Lewy Body DementiaR21AG085401 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI Nagendran Ramalingam · 2024 to 2026
$433k
Gatan K3 Direct Electron Detector Model 1967S10OD036338 · OD · RUTGERS, THE STATE UNIV OF N.J. · PI KAELBER, JASON T · 2024 to 2024
$350k
Alpha Omega Alpha Honor Medical Society (AOA) N/AAresty Research Center summer science research fellowship N/AHHS | National Institutes of Health (NIH) AG085401HHS | National Institutes of Health (NIH) NS122880HHS | National Institutes of Health (NIH) NS133979HHS | National Institutes of Health (NIH) R25NS105143HHS | National Institutes of Health (NIH) R35GM147027HHS | National Institutes of Health (NIH) S10OD036338Jack Kent Cooke Foundation (JKCF) N/ANational Science Foundation (NSF) CAREER MCB-2046180NIA NIH HHS R21 AG085401NIGMS NIH HHS R35 GM147027NIH HHS S10 OD036338NINDS NIH HHS R01 NS122880NINDS NIH HHS R01 NS133979NINDS NIH HHS R25 NS105143NINDS NIH HHS RF1 NS122880NINDS NIH HHS RF1 NS133979Rutgers Health Center for Biomedical Informatics & Health Artificial Intelligence (BMIHAI) summer research internship N/ARutgers startup funding N/A
6 · The paper itself

Abstract

Alpha-synuclein (αSyn) inclusions are a defining neuropathological feature of Parkinson's disease, but the cellular events that initiate their formation and promote neurotoxicity remain incompletely understood. Aberrant liquid-liquid phase separation has emerged as a potential early step in αSyn dysregulation, yet the physiological triggers and functional consequences of this process are unclear. Here, we show that lipid droplets promote the spontaneous phase separation of wild-type and E46K mutant αSyn into condensates. These condensates sequester lipid droplets and impair their turnover, indicating disruption of cellular lipid homeostasis. Mitochondria in close proximity to αSyn condensates exhibit reduced membrane potential and increased mitophagy. Correlative light and electron microscopy further reveals αSyn oligomers associated with mitochondrial membranes displaying structural abnormalities. Together, these findings identify lipid droplets as drivers of aberrant αSyn phase separation and suggest that lipid droplet-rich condensates contribute to mitochondrial dysfunction and impaired energy homeostasis. Given the enrichment of lipid droplets within neuromelanin-containing dopaminergic neurons of the substantia nigra, this mechanism may be relevant to the selective neuronal vulnerability observed in Parkinson's disease.

Indexed as

alpha-SynucleinEnergy MetabolismLipid DropletsAnimalsHomeostasisHumansMembrane Potential, MitochondrialMitochondriaMitophagyParkinson DiseasePhase Separationalpha-Synuclein

Identifiers

PMID42393234
PMCPMC13458734

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.